Purpose
to obtain regulatory approval, manufacture, and deploy at scale the first low-cost, point of care rapid diagnostic test for measles and rubella
Grantee
Division
Global Development
Date
NOVEMBER 2019
Region served
GLOBAL
Committed amount
$2,424,713
Grant topic
Vaccine Delivery
Duration (months)
49
Grantee location
Dakar, Senegal
Related work
More about our financials
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.